BIOM-51. MOLECULAR SUBTYPES, CLINICAL CHARACTERISTICS, AND THERAPEUTIC IMPLICATIONS FOR CNS TUMORS WITH<i>BCOR/BCORL1</i> FUSION/INTERNAL TANDEM DUPLICATION
Johannes Gojo(Medical University of Vienna), Marcel Kool(German Cancer Research Center), L. I. Papusha(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Sanda Alexandrescu(Boston Children's Hospital), Sebastian Brandner(University College London), Damian Stichel(German Cancer Research Center), Christof M. Kramm(Universitätsmedizin Göttingen), Dominik Sturm(German Cancer Research Center), Kristyn Galbraith(NYU Langone Health), Martin Hasselblatt(University Hospital Münster), Jens Bunt(Princess Máxima Center), Jordan R. Hansford, Romain Appay(Aix-Marseille Université), Kornelius Kerl(University Hospital Münster), Evelina Miele(Bambino Gesù Children's Hospital), Andrey Korshunov(Ontario Institute for Cancer Research), Felix Schmitt-Hoffner(German Cancer Research Center), Mariëtte E.G. Kranendonk(Princess Máxima Center), Fouzia Ziad(Waikato Hospital), David Capper(German Cancer Research Center), Dorothee Gramatzki(University Hospital of Zurich), Stefan M. Pfister(Heidelberg University), Michal Zápotocký(Charles University), Jens Pahnke(Latvia University of Life Sciences and Technologies), Zied Abdullaev(National Institutes of Health), Arnault Tauziède‐Espariat(Centre Hospitalier Sainte-Anne), Katharina Bruckner(Comprehensive Cancer Center Vienna), Sumihito Nobusawa(Gunma University), Kenneth Aldape(National Institutes of Health), Felix Sahm(German Cancer Research Center), Ulrich Schüller(Universität Hamburg), Maria Łastowska(Children's Memorial Health Institute), Andrew M. Donson(Children's Hospital Colorado), Katja von Hoff(Universität Hamburg), Pascale Varlet(Inserm), Jasper van der Lugt(Princess Máxima Center), Matija Snuderl, Christine Haberler(Medical University of Vienna), Helen Toledano(Tel Aviv University), Yassine Bouchoucha(Institut Curie), Monika Mauermann(German Cancer Research Center), Martin Sill(German Cancer Research Center), Neal Geisemeyer(German Cancer Research Center), Nicolás André(Aix-Marseille Université), Aniello Federico(German Cancer Research Center), Barbara Jones(German Cancer Research Center), Natalie Jäger(German Cancer Research Center), Tadeja Urbanic-Purkart(Medical University of Graz), David A. Solomon(Stanford University), Mariella G. Filbin(Broad Institute)
Cited by 0
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k